← Browse by Condition
Medical Condition

hr her2 negative breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05683418 Phase 1
Recruiting

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

Enrollment
241 pts
Location
United States, Spain
Sponsor
Totus Medicines
View Trial →